Key Highlights
- CorePharma® is renowned for its regulatory excellence and state-of-the-art facilities, ensuring high-quality pharmaceutical production.
- The company offers a comprehensive, end-to-end solution from early-stage drug development to commercial launch, providing a one-stop platform for pharmaceutical needs.
- With an annual production capacity of 5 billion dosage units, CorePharma® is well-equipped to handle large-scale manufacturing requirements.
- CorePharma®'s industry-leading lead times enable faster transitions from lab to clinic, ultimately reaching patients more efficiently.
- The company's commitment to innovation and operational excellence positions it as a leader in the CDMO industry, making it a valuable partner for pharmaceutical companies.
About CorePharma®
CorePharma® is a leading U.S.-based contract development and manufacturing organization (CDMO) that specializes in delivering high-quality pharmaceuticals across various therapeutic categories. With a comprehensive, end-to-end solution offering from early-stage drug development to commercial launch, CorePharma operates four state-of-the-art facilities, ensuring regulatory excellence and a robust production capacity. Their advanced capabilities support an annual production of 5 billion dosage units, backed by industry-leading lead times.
Founded in 1998, CorePharma has established itself as a trusted partner in the pharmaceutical industry, providing end-to-end services from drug development to commercial manufacturing. The company's commitment to quality and efficiency has made it a preferred choice for many pharmaceutical companies looking to accelerate their product development timelines.
CorePharma's strategic location in Middlesex, New Jersey, and its privately held status further underscore its dedication to maintaining high standards and delivering exceptional results. The company's focus on innovation and operational excellence ensures that it remains at the forefront of the CDMO industry.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
Why Contact CorePharma®?
B2B professionals would contact CorePharma® for its comprehensive CDMO services, regulatory expertise, and ability to accelerate the drug development process. Their advanced manufacturing capabilities and commitment to quality make them an ideal partner for pharmaceutical companies seeking efficient and reliable production solutions.
Who Should Contact CorePharma® for Business?
Sales teams selling pharmaceutical development services, recruiters seeking roles in pharmaceutical manufacturing, and partners offering advanced manufacturing capabilities should reach out to CorePharma®.
Categories
- pharmaceutical manufacturing
- CDMO services
- drug development
- commercial launch
- manufacturing capacity
- regulatory excellence
- end-to-end solutions
- pharmaceutical production
- clinical manufacturing
- commercial packaging
More Pharmaceutical Manufacturing Companies
Frequently Asked Questions
- Who is the CEO of CorePharma®?
- Arpit Patel is the Chief Executive Officer of CorePharma.
- What is Arpit Patel's email at CorePharma®?
- Arpit Patel's email address is arpit.patel@corepharma.com.
- What does CorePharma® do?
- CorePharma is a pharmaceutical company focused on contract development and manufacturing (CDMO) with a commitment to quality and patient health.
- How many employees does CorePharma® have?
- CorePharma® has approximately 156 employees.
- Where is CorePharma® headquartered?
- Middlesex, New Jersey, United States of America
- What industry is CorePharma® in?
- CorePharma® operates in Pharmaceutical Manufacturing, Contract Development and Manufacturing, Pharmaceutical CDMO Services.
- When was CorePharma® founded?
- CorePharma® was founded in 1998.
- What is the email format at CorePharma®?
- CorePharma® uses the email format first.last@corepharma.com.
- Is CorePharma® still active?
- Yes, CorePharma® was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to CorePharma®?
- Research CorePharma®'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to CorePharma®?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with CorePharma®